In this research, the study found that giving albumin to patients with heart failure who have low albumin levels was linked to higher adjusted mortality rates during hospitalization and within 28-days, along with prolonged stays in both the hospital and intensive care unit. The gene discussed is ALB; the disease is heart failure.